Ampio Pharmaceuticals Inc

Ampio Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm engages in the development of therapies to treat prevalent inflammatory conditions. Its product pipeline includes new uses for approved drugs and new molecular entities for important therapeutic areas, including metabolic disease, eye disease, kidney disease, inflammation and sexual dysfunction and CNS disease. The company was founded by David Bar-Or in December 2008 and is headquartered in Englewood, CO.

Earnings data Q2 2020

Earnings data Q3 2020

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Biocept

Boxlight

eMagin

These seven penny stocks have the right catalysts, business models, and tailwinds. Read about why the risk is worth it.

7 Penny Stocks Worth the Danger as Pandemic Catalyzes Growth

Ampio Pharmaceuticals (AMPE) saw a big move last session, as its shares jumped nearly 9% on the day, amid huge volumes.

Ampio Pharmaceuticals (AMPE) Jumps: Stock Rises 8.7%

CytoDyn Inc.

Galectin Therapeutics

Gilead Sciences

Roche Holding AG

Finding The Kink In COVID-19's Armor - Preventing ARDS

Ampio (AMPE) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.

Ampio (AMPE) Looks Good: Stock Adds 5.2% in Session

Investors need to pay close attention to Ampio (AMPE) stock based on the movements in the options market lately.

Implied Volatility Surging for Ampio (AMPE) Stock Options

News for Ampio Pharmaceuticals Inc Stock (AMPE)